Intended for healthcare professionals

  1. Research
  2. Effect of β blockers...
  3. Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
CCBYNC Open access
Research

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2549 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2549

Related articles

See more

Cited by...

  • Effect of {beta}-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
  • Course of DISease In patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls
  • Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study
  • Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
  • Cardiovascular disease and COPD: dangerous liaisons?
  • The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis
  • Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
  • Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease
  • Effect of {beta}-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD
  • Evidence of potential bias in a comparison of {beta} blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
  • Underuse of {beta}-blockers in heart failure and chronic obstructive pulmonary disease
  • Beta-blockers in COPD: time for reappraisal
  • {beta}-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease ({beta}LOCK COPD): a randomised controlled study protocol
  • {beta}-Blockers are associated with a reduction in COPD exacerbations
  • {beta}-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
  • Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up
  • Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
  • Effects of intravenous and oral {beta}-blockade in persistent asthmatics controlled on inhaled corticosteroids
  • Effect of {beta} blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
  • Resting heart rate is a predictor of mortality in COPD
  • {beta}-Blockers for COPD inpatients
  • Pharmacology and Therapeutics of Bronchodilators
  • Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD
  • {beta}-blockers associated with reduced all-cause mortality in COPD
  • Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis
  • Thorax in focus: chronic obstructive pulmonary disease
  • {beta}-Blockers in COPD Patients
  • Treatment with {beta} blockers in people with COPD
Back to top